Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brenipatide versus placebo in adults with uncontrolled moderate to severe asthma
NL-OMON58824Phase 2Recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2 trial of brenipatide in asthma (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Annualized Asthma Exacerbation Rate. Started Jul 2026; status: recruiting.
02
Drugs
brenipatide
03
Conditions
asthma
Beyond the preview
Go deeper on NL-OMON58824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58824.